Citadel Advisors LLC 13D and 13G filings for BridgeBio Oncology Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:09 pm Purchase | 2025-09-30 | 13G | BridgeBio Oncology Therapeutics Inc. BBOT | Citadel Advisors LLC | 2,538,142 3.200% | 2,538,142 (New Position) | Filing |